Hunan Er-Kang Pharmaceutical Co.,Ltd. Posted 36.9 Million Yuan Net Profit in 2022

Hunan Er-Kang Pharmaceutical Co.,Ltd. (湖南尔康制药股份有限公司) (300267.SZ) reported a net profit of 36.9 million yuan in 2022, reversing a net loss of 798.2 million yuan for the previous year.

Meanwhile, the company posted 1.9 billion yuan in revenue, down 16.3% year-on-year.

At the end of the reporting period, it had 5.9 billion yuan in total assets and 804.6 million yuan in total liabilities, with a liability-to-asset ratio of 13.7%.